Moreover, administration of a p110δ inhibitor in 4T1 tumor-bearing mice undermined the function of Tregs and MDSCs, which disrupted tumor immune tolerance and further reignited CD8 + cytotoxic T cell-mediated tumor clearance [59]. Here, CD8A is linked to neoplasm.